Filing Details
- Accession Number:
- 0001567619-21-009481
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-04-30
- Accepted Time:
- 2021-05-10 21:07:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-30 | 341 | $62.41 | 303,839 | No | 5 | A | Direct | |
| Common Stock | Acquisiton | 2021-05-06 | 25,000 | $26.49 | 328,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-06 | 14,825 | $78.01 | 314,014 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-06 | 10,175 | $78.69 | 303,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-05-07 | 25,000 | $26.49 | 328,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-07 | 15,556 | $77.60 | 313,283 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-07 | 6,115 | $78.77 | 307,168 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-07 | 3,329 | $79.39 | 303,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2021-05-06 | 25,000 | $0.00 | 25,000 | $26.49 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2021-05-07 | 25,000 | $0.00 | 25,000 | $26.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 33,513 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
| 8,513 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 247,533 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
Footnotes
- Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-1 plan executed on December 3, 2020, as amended on March 29, 2021.
- The price in column 4 is the weighted average price. The price actually received ranged from $77.375 to $78.37. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $78.38 to $78.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $77.13 to $77.95. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $78.15 to $79.14. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $77.9400 on March 4, 2021. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
- The price in column 4 is the weighted average price. The price actually received ranged from $79.15 to $79.75. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
